최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Endocrine research, v.30 no.1, 2004년, pp.47 - 59
Lewiński, Andrzej (Department of Thyroidology, Medical University of Łó) , Marcinkowska, Magdalena (dź) , Brzeziańska, Ewa (, 5, Dr. Sterling St., 91‐) , Jeziorowska, Anna (425, Łó) , Włoch, Jan (dź) , Brzeziński, Jan (, Poland)
Aim: The aim of this study was to examine the expression of the IGF‐I gene and of genes for IGFBP‐1, ‐2, ‐3, and ‐4 in cells from nodular goiters (NG), and from different human thyroid carcinomas (papillary—PTC, anaplastic—ATC, and medullary—MTC), cultured in monolayers. The influence, exerted by exogenous IGF‐I on the expression of these genes, was also investigated. Methods: Thyroid tissue specimens were obtained from 65 patients during subtotal or total thyroidectomies. After approximately 2–3 weeks of culture, thyroid cells were incubated for 24 hours with IGF‐I in concentrations of: 0, 1, 10 and 100 ng/ml. The total mRNA was isolated according to the method described by Chomczyński and Sacchi with our own modifications. Afterwards, mRNA encoding IGF‐I, IGFBP‐1—IGFBP‐4 and glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH), were amplified, using the reverse transcription‐polymerase chain reaction (RT‐PCR); GAPDH gene served as a control gene. PCR products were electrophoresed and then submitted to densitometric analysis. Results and conclusions: Our study has shown that in carcinoma cells (ATC, PTC, MTC), IGF‐I reveals a stimulatory influence on the expression of its own gene, that effect being most distinctive in ATC cells. These facts indicate an important role of IGF‐I in the pathogenesis and invasiveness of the analyzed malignant neoplasms.
Le Roith, Derek, Bondy, Carolyn, Yakar, Shoshana, Liu, Jun-Li, Butler, Andrew. The Somatomedin Hypothesis: 2001. Endocrine reviews, vol.22, no.1, 53-74.
Growth Factors Eggo M C 99 2 2 1990 10.3109/08977199009071497
Proc Natl Acad Sci U S A Yakar S 7324 96 13 1999 10.1073/pnas.96.13.7324
Eur J Endocrinol Hofbauer L C 605 132 5 1995 10.1530/eje.0.1320605
Endocr Rev Khandwala H M 215 21 3 2000 10.1210/edrv.21.3.0399
Endocrinology Baxter R C 4036 139 10 1998 10.1210/endo.139.10.5083
Endocrinol Metab Clin N Am D'Ercole A J 573 25 3 1996 10.1016/S0889-8529(05)70341-8
Acta Endocrinol (Copenh) Yashiro T 112 121 1 1989 10.1530/acta.0.1210112
Biochem Biophys Res Commun Okimura Y 589 161 2 1989 10.1016/0006-291X(89)92640-5
Eur J Cancer Onoda N 1904 28 11 1992 10.1016/0959-8049(92)90033-X
Mol Cell Endocrinol Rasmussen A K 165 116 2 1996 10.1016/0303-7207(95)03711-X
Anal Biochem Chomczynski P 156 162 1 1987 10.1016/0003-2697(87)90021-2
Science Rappolee D A 708 241 4866 1988 10.1126/science.3041594
Expression von Insulin‐Like Growth Factor Binding Protein 2 (IGFBP‐2) in Leukämischen Lymphozyten. Einfluss von IGF I + II Biemer E 1995
J Clin Endocrinol Metab Minuto F 621 68 3 1989 10.1210/jcem-68-3-621
J Pathol Thomas G A 355 173 4 1994 10.1002/path.1711730411
Br J Cancer Takahashi M H 813 72 4 1995 10.1038/bjc.1995.418
Biochimie Belfiore A 403 81 4 1999 10.1016/S0300-9084(99)80088-1
Cancer Lett Nakahashi K 247 101 2 1996 10.1016/0304-3835(96)04128-6
Thyroid Van der Laan B F 67 5 1 1995 10.1089/thy.1995.5.67
Endocr J Isozaki O S97 43 1996 10.1507/endocrj.43.Suppl_S97
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.